Clinical Trial Update: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical study to evaluate the safety and preliminary efficacy of QI-019B in patients with relapsed or refractory multiple myeloma. The trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• QI-019B

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Multiple Myeloma (MM) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING